【24h】

Oculocutaneous albinism

机译:眼皮肤白化病

获取原文
       

摘要

Oculocutaneous albinism (OCA) is a group of inherited disorders of melanin biosynthesis characterized by a generalized reduction in pigmentation of hair, skin and eyes. The prevalence of all forms of albinism varies considerably worldwide and has been estimated at approximately 1/17,000, suggesting that about 1 in 70 people carry a gene for OCA. The clinical spectrum of OCA ranges, with OCA1A being the most severe type with a complete lack of melanin production throughout life, while the milder forms OCA1B, OCA2, OCA3 and OCA4 show some pigment accumulation over time. Clinical manifestations include various degrees of congenital nystagmus, iris hypopigmentation and translucency, reduced pigmentation of the retinal pigment epithelium, foveal hypoplasia, reduced visual acuity usually (20/60 to 20/400) and refractive errors, color vision impairment and prominent photophobia. Misrouting of the optic nerves is a characteristic finding, resulting in strabismus and reduced stereoscopic vision. The degree of skin and hair hypopigmentation varies with the type of OCA. The incidence of skin cancer may be increased. All four types of OCA are inherited as autosomal recessive disorders. At least four genes are responsible for the different types of the disease (TYR, OCA2, TYRP1 and MATP). Diagnosis is based on clinical findings of hypopigmentation of the skin and hair, in addition to the characteristic ocular symptoms. Due to the clinical overlap between the OCA forms, molecular diagnosis is necessary to establish the gene defect and OCA subtype. Molecular genetic testing of TYR and OCA2 is available on a clinical basis, while, at present, analysis of TYRP1 and MATP is on research basis only. Differential diagnosis includes ocular albinism, Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, Griscelli syndrome, and Waardenburg syndrome type II. Carrier detection and prenatal diagnosis are possible when the disease causing mutations have been identified in the family. Glasses (possibly bifocals) and dark glasses or photocromic lenses may offer sufficient help for reduced visual activity and photophobia. Correction of strabismus and nystagmus is necessary and sunscreens are recommended. Regular skin checks for early detection of skin cancer should be offered. Persons with OCA have normal lifespan, development, intelligence and fertility.
机译:眼皮肤白化病(OCA)是一组遗传性黑色素生物合成疾病,其特征是头发,皮肤和眼睛的色素沉着普遍减少。在世界范围内,各种形式的白化病的患病率差异很大,估计约为1 / 17,000,这表明70人中约有1人携带OCA基因。 OCA的临床范围很广,其中OCA1A是最严重的类型,一生中完全不产生黑色素,而较温和的形式OCA1B,OCA2,OCA3和OCA4随着时间的推移会出现一些色素积聚。临床表现包括各种程度的先天性眼球震颤,虹膜色素沉着和半透明,视网膜色素上皮色素沉着减少,中央凹发育不全,视力通常降低(20/60至20/400)和屈光不正,色觉障碍和明显的畏光。视神经错觉是一个特征性发现,导致斜视和视力下降。皮肤和头发色素沉着的程度随OCA类型的不同而不同。皮肤癌的发病率可能会增加。所有四种类型的OCA都被遗传为常染色体隐性遗传疾病。至少四个基因负责不同类型的疾病(TYR,OCA2,TYRP1和MATP)。诊断基于皮肤和头发色素沉着不足的临床发现,以及特征性的眼部症状。由于OCA形式之间的临床重叠,因此需要分子诊断来确定基因缺陷和OCA亚型。 TYR和OCA2的分子遗传学测试可在临床上进行,而目前TYRP1和MATP的分析仅在研究基础上。鉴别诊断包括眼白化病,Hermansky-Pudlak综合征,Chediak-Higashi综合征,Griscelli综合征和Waardenburg综合征II型。如果在家庭中已经发现引起突变的疾病,则可以进行携带者检测和产前诊断。眼镜(可能是双焦点眼镜)和墨镜或隐形眼镜可能会为减少视觉活动和畏光提供足够的帮助。需要矫正斜视和眼球震颤,建议使用防晒霜。应提供定期皮肤检查以及早发现皮肤癌。 OCA患者的寿命,发育,智力和生育能力正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号